Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > So the LIFE financing gave them the minimum $3,5M CAD

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Nov 18, 2023 11:32am

171 Views

Post# 35742574

RE:So the LIFE financing gave them the minimum $3,5M CAD

Theralase dropped the issue size from $3.5 - $5 mil to $1.5 mil......As $1.5 mil does not give the co. available funds for 12 months it can't do a LIFE (with no restricted period). Instead it must do a private placement with a 4 month hold period.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?